JP2002540146A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002540146A5 JP2002540146A5 JP2000607616A JP2000607616A JP2002540146A5 JP 2002540146 A5 JP2002540146 A5 JP 2002540146A5 JP 2000607616 A JP2000607616 A JP 2000607616A JP 2000607616 A JP2000607616 A JP 2000607616A JP 2002540146 A5 JP2002540146 A5 JP 2002540146A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclic
- phenyl
- pharmaceutical composition
- disease
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12917899A IL129178A0 (en) | 1999-03-25 | 1999-03-25 | Induction of nerve generation |
| IL129178 | 1999-03-25 | ||
| PCT/IL2000/000185 WO2000057865A2 (en) | 1999-03-25 | 2000-03-24 | Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002540146A JP2002540146A (ja) | 2002-11-26 |
| JP2002540146A5 true JP2002540146A5 (enExample) | 2005-05-19 |
Family
ID=11072645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000607616A Pending JP2002540146A (ja) | 1999-03-25 | 2000-03-24 | 神経細胞分化を促進するための環状グリセロリン酸とその類似体を含む医薬組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6914056B1 (enExample) |
| EP (1) | EP1162959B1 (enExample) |
| JP (1) | JP2002540146A (enExample) |
| KR (1) | KR20010112364A (enExample) |
| CN (1) | CN1348375A (enExample) |
| AT (1) | ATE290385T1 (enExample) |
| AU (1) | AU768911B2 (enExample) |
| BR (1) | BR0009296A (enExample) |
| CA (1) | CA2368597A1 (enExample) |
| DE (1) | DE60018554T2 (enExample) |
| HK (1) | HK1042038A1 (enExample) |
| IL (1) | IL129178A0 (enExample) |
| MX (1) | MXPA01009650A (enExample) |
| NZ (1) | NZ514525A (enExample) |
| RU (1) | RU2247557C2 (enExample) |
| WO (1) | WO2000057865A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69912808T2 (de) | 1999-12-08 | 2004-09-30 | Centre National De La Recherche Scientifique (C.N.R.S.) | Verwendung von Hymenialdisin und dessen Derivaten zur Herstellung therapeutischer Mittel |
| JP4836345B2 (ja) * | 2001-04-13 | 2011-12-14 | きみ子 室伏 | 環状ホスファチジン酸誘導体を含む神経細胞の生存促進剤 |
| JP4815063B2 (ja) * | 2001-04-13 | 2011-11-16 | きみ子 室伏 | 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び／又は生存の促進のための薬剤 |
| IL148668A0 (en) * | 2002-03-13 | 2002-09-12 | Yeda Res & Dev | Derivatives of 1,3-cyclic propandiol phosphate and their action in differentiation therapy |
| IL148665A0 (en) * | 2002-03-13 | 2002-09-12 | Yeda Res & Dev | Derivatives of 1,3-cyclic propandiol phate and their action as cell stimulants |
| AU2003220521A1 (en) * | 2002-03-27 | 2003-10-13 | Smithkline Beecham Corporation | Methods of treatment with lxr modulators |
| JP4162927B2 (ja) | 2002-06-11 | 2008-10-08 | きみ子 室伏 | カルバ環状ホスファチジン酸誘導体 |
| US8101552B2 (en) * | 2005-03-14 | 2012-01-24 | Yeda Research And Development Company Ltd. | Cyclic phosphates as plant growth regulators |
| ES2518371T3 (es) * | 2006-04-26 | 2014-11-05 | Toyama Chemical Co., Ltd. | Inductor de la neurogénesis o agente terapéutico para la neuropatía que comprende un derivado de éter alquílico o una sal del mismo |
| KR20090097943A (ko) * | 2006-12-28 | 2009-09-16 | 오짜노미즈 유니버시티 | 환상 포스파티딘산 유도체를 포함하는 진통제 |
| EP2389348B1 (en) * | 2009-01-09 | 2017-11-15 | Sigma-Aldrich Co. LLC | Process for the synthesis of beta glycerol phosphate |
| WO2011065480A1 (ja) * | 2009-11-26 | 2011-06-03 | 国立大学法人お茶の水女子大学 | 神経細胞死抑制剤 |
| WO2014115885A1 (ja) | 2013-01-28 | 2014-07-31 | 国立大学法人お茶の水女子大学 | 脱髄疾患治療薬 |
| EP2807925A1 (en) * | 2013-05-26 | 2014-12-03 | Symrise AG | Antimicrobial compositions |
| EP3386995A1 (en) * | 2015-12-08 | 2018-10-17 | Retrophin, Inc. | Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL63037A (en) * | 1981-06-04 | 1985-12-31 | Israel State | Dioxaphosphorinanes,their preparation and pharmaceutical and veterinary compositions containing them |
| US5565439A (en) * | 1992-11-24 | 1996-10-15 | The Procter & Gamble Company | Methods of using lysophosphatidic acid for treating hyperproliferative conditions |
| JPH06228169A (ja) * | 1993-02-05 | 1994-08-16 | Sagami Chem Res Center | １−ｏ−アシルグリセロール２，３−ホスフェートの製造法 |
| JPH07149772A (ja) * | 1993-11-26 | 1995-06-13 | Sagami Chem Res Center | タンパク質リン酸化酵素ｃの活性促進剤 |
| JPH07258278A (ja) * | 1994-03-18 | 1995-10-09 | Sagami Chem Res Center | １−Ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするＤＮＡポリメラーゼαの阻害剤 |
| JPH0925235A (ja) * | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | １−ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするがん転移抑制剤 |
| US6150345A (en) * | 1998-08-10 | 2000-11-21 | Regents Of The University Of California | Methods for promoting survival of myelin producing cells |
| IL129179A0 (en) | 1999-03-25 | 2000-02-17 | Yeda Res & Dev | Cyclic glycerophosphates and analogs thereof |
-
1999
- 1999-03-25 IL IL12917899A patent/IL129178A0/xx unknown
-
2000
- 2000-03-24 KR KR1020017012158A patent/KR20010112364A/ko not_active Withdrawn
- 2000-03-24 WO PCT/IL2000/000185 patent/WO2000057865A2/en not_active Ceased
- 2000-03-24 AT AT00912877T patent/ATE290385T1/de not_active IP Right Cessation
- 2000-03-24 NZ NZ514525A patent/NZ514525A/en unknown
- 2000-03-24 JP JP2000607616A patent/JP2002540146A/ja active Pending
- 2000-03-24 EP EP00912877A patent/EP1162959B1/en not_active Expired - Lifetime
- 2000-03-24 DE DE60018554T patent/DE60018554T2/de not_active Expired - Fee Related
- 2000-03-24 CA CA002368597A patent/CA2368597A1/en not_active Abandoned
- 2000-03-24 MX MXPA01009650A patent/MXPA01009650A/es not_active Application Discontinuation
- 2000-03-24 CN CN00806738A patent/CN1348375A/zh active Pending
- 2000-03-24 HK HK02101620.4A patent/HK1042038A1/zh unknown
- 2000-03-24 BR BR0009296-7A patent/BR0009296A/pt not_active IP Right Cessation
- 2000-03-24 US US09/936,922 patent/US6914056B1/en not_active Expired - Fee Related
- 2000-03-24 RU RU2001128743/15A patent/RU2247557C2/ru not_active IP Right Cessation
- 2000-03-24 AU AU34517/00A patent/AU768911B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69333632T2 (de) | Substituierte aminoalkylverbindungen | |
| Wecker et al. | Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia | |
| Kida et al. | Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn | |
| EP1071409A2 (de) | Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen | |
| JP2019510039A5 (enExample) | ||
| CA2501799A1 (en) | Pyrazole compounds for treatment of neurodegenerative disorders | |
| RU2001128743A (ru) | Фармацевтические композиции, включающие циклические глицерофосфаты и их аналоги, для активации дифференцировки нервных клеток | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| JP2011516588A5 (enExample) | ||
| EP1095050A1 (de) | Phosphororganische verbindungen und ihre verwendung | |
| JP2006524243A (ja) | 増強認知訓練 | |
| EP1140113B1 (de) | Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen | |
| BR0009296A (pt) | Composição farmacêutica, processos para induzirpromoção de diferenciação de células neurais decélulas-alvo, para promover atividade neural emum indivìduo, e para prevenção ou tratamento dedistúrbios e doenças que podem ser prevenidos outratados por meio de promoção de diferenciaçãode células neurais e/ou de atividade neural, e, usode um composto | |
| DE19920247A1 (de) | Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung | |
| DE60133385T2 (de) | (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen | |
| US20090306015A1 (en) | Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds | |
| JP2002535334A5 (enExample) | ||
| DE60123528T2 (de) | Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit | |
| KR930017882A (ko) | 아미노 벤조산 유도체 | |
| HUP0200145A2 (hu) | Tianeptin alkalmazása neurodegeneratív betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| ATE402150T1 (de) | Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen | |
| WO2020182144A1 (zh) | 用于治疗神经退行性疾病的化合物 | |
| RU2007112950A (ru) | Новые производные 3,5-секо-4-норхолестана и их применение | |
| JPH05506441A (ja) | 加齢関連記憶障害およびその他の認識障害の治療のための化合物 | |
| DE60307049T2 (de) | Verwendung von Piperazin- Phenothiazin- Derivaten zur Herstellung eines Arzneimittels mit neuroprotektiven und/oder neurotropischen Wirkungen auf das ZNS und/oder PNS |